Biologically, the activation of FOXM1 by CDK4/6 is critical for CDK4/6-mediated cell cycle entry, suppressing the levels of reactive oxygen species (ROS), and protecting cancer cells (breast, melanoma, sarcoma) from senescence [67]. Here, CDK4 is linked to cancer.